Patrick Cox has lived deep inside the world of transformative technologies for over 25 years. In the 1980s, he worked in computer software development and manufacturing. By the mid-1990s, he worked as a consultant for Netscape — the company that handled 90% of all Internet browsing traffic at the time. InfoWorld and USA Today have featured Patrick's research numerous times. He's also appeared on Crossfire and Nightline. Patrick has been quoted by The Wall Street Journal and Reason magazine. His expertise brought him to Agora Financial, where he now heads Breakthrough Technology Alert, the only place you'll find the truly transformational technologies that offer exponential gains.
Fascination with the effects of electricity on the body goes back — way back.
In the 1770s Italian physician and physicist Luigi Galvani shocked the world with the discovery that a spark could cause a dead frog’s legs to twitch.
In 1802, German chemist Johann Wilhelm Ritter furthered Galvani’s research into electrophysiology. ...read more
In the last year, I’ve met several investors who have made many hundreds of thousands of dollars by investing relatively small amounts in the companies that I write about most regularly. They have done so by “trading the channel.” This means they buy a stock they want more of when ...read more
There is revolutionary work going on right now at a major university hospital in Texas...
This current work seems to have come up with a treatment that makes patients lose weight. How does it work?
It goes right after fat cells themselves...
The super-simple way to explain it is that this treatment cuts ...read more
The sickle cell trait has its origins in a genetic adaptation common in individuals in which the mosquito-borne disease, malaria, has impacted human life for thousands of years. In sub-Saharan Africa, for example, as many as one-third of people carry the gene. It is also found, although less commonly, in ...read more
One company’s stock is grossly underrated these days, as are many small-cap biotechs. Market psychology often disguises the long-term value of a company.
In my opinion,there is no company that has a bigger platform and a more undervalued stock...
The platform is nonembryonic human parthenogenetic (often shortened to “parthenogenic”) stem cells (hpSCs). ...read more
It is getting harder and harder, in fact, to keep up with all of the breakthroughs coming out of the biotech, as so much news is coming from this sector.
I’m still astounded by one announcement made recently...
Scientists have identified the gene that locks down inactive DNA — SP100.
Let me explain.
The ...read more
The world-famous Ludwig Institute for Cancer Research in Belgium is funding a Phase 1/2 clinical test of a cancer vaccine. This complex carbohydrate blocks galectin-3s.
Briefly, galectins-3s are proteins that have the ability to recognize and attach themselves to specific sugar molecules. This sugar-binding characteristic is typical of all lectins and ...read more
Scientists are very interested in bacteria for a number of reasons. Among the most recent is that they can be used to manufacture various important chemicals, including fuels.
We tend not to think about it, but the single-cell microorganisms categorized as bacteria are the dominant life form on Earth. In some ...read more
More and more often, I’m finding “too good to be true” technologies that are, in fact, very true.
It is, I think, the hallmark of our era.
Things we thought were impossible are coming to pass on a regular basis. To prosper, we’ll all have to re-examine practically everything we thought we ...read more
I’ve spoken with scores of doctors and scientists who are using or recommending the use of one nutraceutical. These recommendations, however, were not based on clinical evidence. Rather, they come from the personal experiences of many in the research community who have seen remarkable improvements in health.
In scientific circles, this ...read more
Penny stocks, options, and emerging market plays offer some of the best gain potential in the investment world. The Penny Sleuth features unbiased and independent analysis on penny stocks, OTCBB, options and more!
